GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
RATIONALE: GSAO may stop the growth of solid tumors by blocking blood flow to the tumor.
PURPOSE: This phase I trial is studying the side effects and best dose of GSAO in treating
patients with advanced solid tumors that have not responded to therapy.